Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-06-06
1998-04-21
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514213, 514278, 514323, 540543, 540586, 540593, 540597, 546 16, 546 17, 546101, 546140, 546143, 546177, 546187, 546195, 546201, C07D22700, C07D40112, A61K 31395, A61K 31445
Patent
active
057417890
ABSTRACT:
A series of hetero-oxy alkanamines are effective pharmaceuticals for the treatment of conditions related to or affected by the reuptake of serotonin and by the serotonin 1.sub.A receptor. The compounds are particularly useful for alleviating the symptoms of nicotine and tobacco withdrawal, and for the treatment of depression and other conditions for which serotonin reuptake inhibitors are used.
REFERENCES:
patent: 3929793 (1975-12-01), Popelak et al.
patent: 4146630 (1979-03-01), Kampe et al.
patent: 4244961 (1981-01-01), Kluge et al.
patent: 4288442 (1981-09-01), Friebe et al.
patent: 4304915 (1981-12-01), Berthold
patent: 4361562 (1982-11-01), Berthold
patent: 4460586 (1984-07-01), Berthold
patent: 4803203 (1989-02-01), Caprathe et al.
patent: 4849431 (1989-07-01), Sugimoto et al.
patent: 4935414 (1990-06-01), Stenzel et al.
patent: 5013761 (1991-05-01), Beedle et al.
Hall et al., Brain Research 745 (1997) 96-108.
Raymond et al., Am. M. Physiol., 1993, vol. 264, No. 1, part 2, pp. F9-F19.
Hoyer et al., Brain Researh 376 (1986) 85-86.
Sanchez et al., European J. Pharmacology, 315 (1996) 245-254.
De Vry et al., Drug Development Research vol. 30, No. 2, pp. 91-103 (1993).
Schreiber et al., Prog. Neuro-Psychopharmacol. & Biol. Psychiat. (1993), vol. 17, pp. 87-104.
Pitchot et al., Pharmacopsychiatry (1995), vol. 28 (supplement) pp. 91-92.
Coccaro et al., International Clinical Psychopharmacology, (1995), 10, 177-179.
Simpson et al., Proceedings of the BPS, 14-16 Jul. 1993.
Krystal, Journal of Clinical Psychiatrty, (1996), V. 57, S. 10, pp. 22-23.
Mutschler et al. "drug Actions, Basic Principles and Therapeutic Aspects", published 1995 by Medpharm Scientific Publishers (Stuttgart), pp. 309-312.
West, et al., Psychopharmacology, 104, 91-96 (1991).
Hilleman, et al., Arch. Intern. Med., 152, 350-352 (1992).
Artigas, TiPs, 14, 262 (1993).
Fuller, Life Sciences, 55, 163-167 (1994).
Jacobsen, J. Clin. Psychiatry, 52, 217-220 (1991).
Hjorth, J. Neurochem., 60, 776-779 (1993).
Artigas, et al., Arch. Gen. Psychiatry, 51, 248-251 (1994).
Hoey, et al., European J. of Pharm., 231, 477-480, (1993).
Marxer, et al., J. Org. Chem., 40, 1427-1433 (1975).
Parham, et al., J. Org. Chem., 41, 2628-2635 (1976).
Yamato, et al., J. Med. Chem., 24, 194-198 (1981).
Evans, et al., J. Med. Chem., 35, 3919-3927 (1992).
Efange, et al., J. Med. Chem., 37, 2574-2582 (1994).
Chambers, et al., J. Med. Chem., 35, 2033-2039 (1992).
Armah, et al., Br. J. Pharmacol., 96, 807-816 (1989).
Derwent Abstract, Japanese 2121-924-A.
Derwent Abstract, Japanese 2121-966-A.
Raina. Antihistominic Activity of Synthetic Quinoline Derivatives. Indian J. Med Res. (59) 614-26, (1971).
Bennur. 1-Substituted Alkylamino-3-(4-quinazolyhoxy)-2-Propanol . . . Revue Roumaine de Chimie, 20, 9-10, 1295-99 (1975).
Mehrotra. Substituted Quinoline as menoamine oxidase inhibitors and analyesies. Chem Abstracts 98:143248.
Faye et al. Principles of Medicinal Chemistry, 4th ed. Williams & Wilkins 1995 p. 199.
Mehrotra, et al., Indian J. Physiol. Pharmacol., 26(3), 253-7 (1982).
Hibschman David J.
Krushinski, Jr. Joseph H.
Rasmussen Kurt
Rocco Vincent P.
Schaus John M.
Boone David E.
Eli Lilly and Company
Kifle Bruck
Palmberg Arleen
Shah Mukund J.
LandOfFree
Compounds having effects on serotonin-related systems does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds having effects on serotonin-related systems, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds having effects on serotonin-related systems will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2057638